# Commission Decision of 10 February 2011 authorising a laboratory in the Republic of Korea to carry out serological tests to monitor the effectiveness of rabies vaccines (notified under document C(2011) 656) (Text with EEA relevance) (2011/91/EU), Article 1

Extent: E+W+S+N.I.

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratory is authorised to perform the serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets:
Komipharm International Co. Ltd
1236-6 Jeoungwang-dong
420-450 Siheung-si, Gyeonggi-do
South Korea

---
Source: https://www.legislation.gov.uk/eudn/2011/91/article/1 (the official version)
Page: https://openlegislation.uk/eu-decision-2011-91/article-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.